CalciMedica is trading 7.66% higher at $1.15, with no clear company-specific reason identified for the October 15 rise.

  • The company’s press-release page showed no release dated October 15 in the available results.
  • U.S. stocks were under pressure after hotter-than-expected September CPI, with the Nasdaq down 1.9% in reported trading; this backdrop does not explain CalciMedica’s gain.